Dallas, Texas (PRWEB) October 21, 2012
In 2011, the global ophthalmology therapeutics market was estimated to be around $10 billion, growing at a Compound Annual Growth Rate (CAGR) of 7.2% between 2004 and 2011. The glaucoma market was the largest segment followed by Wet-AMD. These segments accounted for 36% and 32% of the global ophthalmology therapeutics market in 2011, respectively. The decline in glaucoma revenue due to significant generic erosion will change the therapeutic landscape until 2018, when glaucoma is expected to account for 23%, a decline of 13% relative to 2011, and the wet-AMD market is expected to account for 37% of the global ophthalmology market, an increase of 5% relative to 2011. The decline in the glaucoma market is expected to be offset by a healthy growth in the wet-AMD, DME, and DES markets. These markets are expected to grow due to the presence of considerable unmet need and increasing treatment-seeking and diagnosis rates.
The top pharmaceutical companies in the ophthalmology market are Pfizer Inc., Allergan Inc., Alcon Inc, Novartis AG., Merck & co. Inc and Roche. Approximately 70% of the market is covered by these six companies.
Scope of the report “Ophthalmology Therapeutics Market to 2018 - Dosing Convenience and Cost-effectiveness Continue to Drive Eylea’s Prescription Share in Wet Age-Related Macular Degeneration (Wet-AMD)” covers:
Buy your copy of this report @ http://www.reportsnreports.com/reports/196660-ophthalmology-therapeutics-market-to-2018-dosing-convenience-and-cost-effectiveness-continue-to-drive-eyleas-prescription-share-in-wet-age-related-macular-degeneration-wet-amd-.html.
The ophthalmology drugs and devices market is divided into four major segments, namely, surgical devices, diagnostic and monitoring devices, vision care, and drugs. The devices market is divided into applications like surgery and diagnostics. Drugs market is classified into existing treatment drugs and drugs in pipeline and the vision care market is segmented into spectacles and contact lenses. The total market is forecasted till 2017. This market is also considered by formulation types such as capsules, gels, eye drops, ointment, and eye solutions.
The geographies covered in this study are North America, Europe, Asia-Pacific (APAC) and Rest of the world (RoW). North America is the largest market for ophthalmology drugs and devices, followed by Europe and Asia. North America and Europe is expected to grow at a slower pace, primarily due to the economic slowdown and saturation in these markets. APAC is an unsaturated market, especially China and India, and these regions are expected to drive the growth of the overall ophthalmology market, mainly due to growing awareness of eye diseases and increasing disposable income.
Scope of the report “Ophthalmology Devices and Drugs Market (Contact Lens, OCT Scanner, IOL, Dry Eye, AMD, Glaucoma) Competitive Landscape & Global Forecasts To 2017”
The research report categorizes the global ophthalmology drugs and devices market into diagnostic devices, surgical devices, vision care and drugs.
Diagnostic and monitoring devices
Surgical devices Market
Global ophthalmology drugs market, by indication:
The report only covers those drugs that are in late Phase 3 or those that have cleared Phase 3 clinical trials for pipeline analysis and forecasting.
Buy your copy of this report @ http://www.reportsnreports.com/reports/187192-ophthalmology-devices-and-drugs-market-contact-lens-oct-scanner-iol-dry-eye-amd-glaucoma-competitive-landscape-global-forecasts-to-2017.html.
Browse more reports on the Pharmaceuticals market @ http://www.reportsnreports.com/market-research/pharmaceuticals/ and the Medical Devices industry @ http://www.reportsnreports.com/market-research/medical-devices/.
Contact sales(at)reportsandreports(dot)com for further information.
ReportsnReports.com (http://www.reportsnreports.com/ ) is an online market research reports library of 200,000+ in-depth studies of over 5000 micro markets. Our database includes reports by leading publishers from across the globe. We provide 24/7 online and offline support service to our customers.